Our findings highlight the potential of targeting NSUN2 lactylation and inhibiting m5C modification as promising strategies to prevent PNI and improve therapeutic outcomes in pancreatic cancer. This evidence concerns the gene NSUN2 and familial pancreatic carcinoma.